Key result
Rare genetic variants previously implicated in lone or familial atrial fibrillation were not associated with AF (P>0.1 for all 19 variants).
Why the study?
Are rare genetic variants previously associated with lone or familial atrial fibrillation associated with atrial fibrillation in a general population cohort?
Case-Control (n=20,204)
Are rare genetic variants previously associated with lone or familial atrial fibrillation associated with atrial fibrillation in a general population cohort?
p-value: p=>0.1
Rare genetic variants previously implicated in lone or familial atrial fibrillation are detected at low frequencies in a general population but are not associated with AF, emphasizing the need for caution when ascribing variants as pathogenic.
Requires caution ascribing these variants as pathogenic for AF; challenges prior familial reports and leaves open validation in broader cohorts.
BACKGROUND: Studies in individuals or small kindreds have implicated rare variants in 25 different genes in lone and familial atrial fibrillation (AF) using linkage and segregation analysis, functional characterization, and rarity in public databases. Here, we used a cohort of 20 204 patients of European or African ancestry with electronic medical records and exome chip data to compare the frequency of AF among carriers and noncarriers of these rare variants. METHODS AND RESULTS: The exome chip included 19 of 115 rare variants, in 9 genes, previously associated with lone or familial AF. Using validated algorithms querying a combination of clinical notes, structured billing codes, ECG reports, and procedure codes, we identified 1056 AF cases (>18 years) and 19 148 non-AF controls (>50 years) with available genotype data on the Illumina HumanExome BeadChip v.1.0 in the Vanderbilt electronic medical record-linked DNA repository, BioVU. Known correlations between AF and common variants at 4q25 were replicated. None of the 19 variants previously associated with AF were over-represented among AF cases (P>0.1 for all), and the frequency of variant carriers among non-AF controls was >0.1% for 14 of 19. Repeat analyses using non-AF controls aged >60 (n=14 904), >70 (n=9670), and >80 (n=4729) years did not influence these findings. CONCLUSIONS: Rare variants previously implicated in lone or familial forms of AF present on the exome chip are detected at low frequencies in a general population but are not associated with AF. These findings emphasize the need for caution when ascribing variants as pathogenic or causative.
No takes yet. Share an insight, caveat, or question.
Weeke et al. (2014) conducted a case-control in Atrial fibrillation (n=20,204). Rare genetic variants previously associated with lone or familial AF vs. Noncarriers was evaluated on Over-representation of rare variants among AF cases (p=>0.1). Rare genetic variants previously implicated in lone or familial atrial fibrillation were not associated with AF (P>0.1 for all 19 variants).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: